The French pharmaceutical group Sanofi announced Tuesday that Plaquenil, the antimalarial drug it produces, has demonstrated "promising" results in treating patients with the emerging coronavirus.
The company added that it was ready to provide millions of doses to the French authorities, which is sufficient to treat 300,000 potential patients.
"In the light of the encouraging results of a study conducted on this medicine," Sanofi pledges to put its medicine within France's reach and provide millions of doses, a quantity that could enable the treatment of 300,000 patients.
At the same time, the spokesman stressed that the group is ready to cooperate with the French authorities "to confirm these results."
The French pharmaceutical company is cooperating with the United States government to use the so-called "recombinant DNA platform" to produce a possible vaccine.
It is noteworthy that the virus has killed at least 7,408 people around the world since it appeared in December 2019, according to an AFP tally based on official sources.
China, from which the virus originated, counted 80,881 infections and 3226 deaths with the recovery of 68,869. Among the countries most affected were Italy, with 2,158 deaths, 27,980 injuries, Iran with 988 deaths and 16,969 infections, and Spain with 491 deaths and 11,178 infections, and France, which saw 148 deaths And 6633 injury.
source : website
0 Commentaires